You are here

  • Home
  • Archive
  • Volume 11, Issue 10
  • Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer

 

Online download statistics by month:

Online download statistics by month: October 2023 to July 2025

AbstractFullPdf
Oct 2023569570234
Nov 2023346350154
Dec 2023192193128
Jan 2024131132118
Feb 2024999988
Mar 2024178178162
Apr 2024129134114
May 2024989996
Jun 202411011375
Jul 202411511673
Aug 2024636264
Sep 2024787959
Oct 2024777783
Nov 2024125126100
Dec 202415615787
Jan 202510510561
Feb 202523423570
Mar 202513813885
Apr 202513713795
May 202512412698
Jun 2025818154
Jul 2025110
Total328633082098